Officer received an award of 246K AVTR derivative securities | OQRO
Home › Insider trades › Avantor › Officer received an award of 246K AVTR derivative securities
Why it stands out Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
Transaction date May 1, 2026
Reporting period Not applicable
Filed with the SEC May 5, 2026 Officer Grant / award
Context Classification grant award
Code A — grant or award
Planned / mechanical clue Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0001628280-26-030825
Filed / recorded
May 5, 2026, 11:40 PM UTC
Added to OQRO Oct 6, 2026, 4:40 PM UTC
Data quality Verified: identifiers matched exactly
Reporting person Ludovic Brellier
Officer title EVP, Bioscience & Medtech
Security Stock Options (Right to Buy)
Table Derivative (Table II)
Transaction date May 1, 2026
Acquired / disposed Acquired (A)
Shares owned after 246,002
Footnotes from the filing Reflects a grant of stock options that vest in three equal annual installments beginning on May 1, 2027.
Around the same time Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
A board member of Avantor paid $83K out of pocket for Avantor shares. 1 other person at Avantor bought some too, in the same month. The Avantor shares held grew by 20%.